80 related articles for article (PubMed ID: 23869866)
1. Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices.
Enrico A; Patrizia G; Luisa P; Alessandro P; Gianluigi L; Carlo G; Maurizio B
J Integr Neurosci; 2013 Jun; 12(2):285-97. PubMed ID: 23869866
[TBL] [Abstract][Full Text] [Related]
2. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W
Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Matthews RT; Yang L; Jenkins BG; Ferrante RJ; Rosen BR; Kaddurah-Daouk R; Beal MF
J Neurosci; 1998 Jan; 18(1):156-63. PubMed ID: 9412496
[TBL] [Abstract][Full Text] [Related]
4. Facile High-Performance Liquid Chromatography Mass Spectrometry Method for Analysis of Cyclocreatine and Phosphocyclocreatine in Complex Mixtures of Amino Acids.
Tao D; Leister W; Huang W; Alimardanov A; LeClair CA
J Agric Food Chem; 2019 Jun; 67(25):7190-7196. PubMed ID: 31194545
[TBL] [Abstract][Full Text] [Related]
5. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
Griffiths GR; Walker JB
J Biol Chem; 1976 Apr; 251(7):2049-54. PubMed ID: 1270421
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic assays for free and phosphorylated derivatives of the creatine analogues beta-guanidopropionic acid and 1-carboxy-methyl-2-iminoimidazolidine (cyclocreatine).
Wiseman RW; Moerland TS; Chase PB; Stuppard R; Kushmerick MJ
Anal Biochem; 1992 Aug; 204(2):383-9. PubMed ID: 1443539
[TBL] [Abstract][Full Text] [Related]
8. Cyclocreatine Transport by SLC6A8, the Creatine Transporter, in HEK293 Cells, a Human Blood-Brain Barrier Model Cell, and CCDSs Patient-Derived Fibroblasts.
Uemura T; Ito S; Masuda T; Shimbo H; Goto T; Osaka H; Wada T; Couraud PO; Ohtsuki S
Pharm Res; 2020 Mar; 37(3):61. PubMed ID: 32124083
[TBL] [Abstract][Full Text] [Related]
9. Searching for a therapy of creatine transporter deficiency: some effects of creatine ethyl ester in brain slices in vitro.
Adriano E; Garbati P; Damonte G; Salis A; Armirotti A; Balestrino M
Neuroscience; 2011 Dec; 199():386-93. PubMed ID: 21963865
[TBL] [Abstract][Full Text] [Related]
10. Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency.
Garbati P; Adriano E; Salis A; Ravera S; Damonte G; Millo E; Balestrino M
Neurochem Res; 2014 Jan; 39(1):37-45. PubMed ID: 24213972
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of rate of tumor growth by creatine and cyclocreatine.
Miller EE; Evans AE; Cohn M
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3304-8. PubMed ID: 8475072
[TBL] [Abstract][Full Text] [Related]
12. Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency.
Do MT; Cavagnaro J; Butt M; Terse PS; McKew JC
Regul Toxicol Pharmacol; 2021 Jul; 123():104939. PubMed ID: 33961952
[TBL] [Abstract][Full Text] [Related]
13. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
Kristensen CA; Askenasy N; Jain RK; Koretsky AP
Br J Cancer; 1999 Jan; 79(2):278-85. PubMed ID: 9888469
[TBL] [Abstract][Full Text] [Related]
14. Creatine and cyclocreatine attenuate MPTP neurotoxicity.
Matthews RT; Ferrante RJ; Klivenyi P; Yang L; Klein AM; Mueller G; Kaddurah-Daouk R; Beal MF
Exp Neurol; 1999 May; 157(1):142-9. PubMed ID: 10222117
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and accumulation of an extremely stable high-energy phosphate compound by muscle, heart, and brain of animals fed the creatine analog, 1-carboxyethyl-2-iminoimidazolidine (homocyclocreatine).
Roberts JJ; Walker JB
Arch Biochem Biophys; 1983 Feb; 220(2):563-71. PubMed ID: 6824340
[TBL] [Abstract][Full Text] [Related]
16. In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase.
Cui MH; Jayalakshmi K; Liu L; Guha C; Branch CA
NMR Biomed; 2015 Dec; 28(12):1634-44. PubMed ID: 26451872
[TBL] [Abstract][Full Text] [Related]
17. The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds.
Lunardi G; Parodi A; Perasso L; Pohvozcheva AV; Scarrone S; Adriano E; Florio T; Gandolfo C; Cupello A; Burov SV; Balestrino M
Neuroscience; 2006 Nov; 142(4):991-7. PubMed ID: 16949212
[TBL] [Abstract][Full Text] [Related]
18. Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
Patel R; Ford CA; Rodgers L; Rushworth LK; Fleming J; Mui E; Zhang T; Watson D; Lynch V; Mackay G; Sumpton D; Sansom OJ; Vande Voorde J; Leung HY
Cancer Res; 2022 Jul; 82(14):2565-2575. PubMed ID: 35675421
[TBL] [Abstract][Full Text] [Related]
19. Preincubation with creatine enhances levels of creatine phosphate and prevents anoxic damage in rat hippocampal slices.
Carter AJ; Müller RE; Pschorn U; Stransky W
J Neurochem; 1995 Jun; 64(6):2691-9. PubMed ID: 7760049
[TBL] [Abstract][Full Text] [Related]
20. Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.
Mulvaney PT; Stracke ML; Nam SW; Woodhouse E; O'Keefe M; Clair T; Liotta LA; Khaddurah-Daouk R; Schiffmann E
Int J Cancer; 1998 Sep; 78(1):46-52. PubMed ID: 9724093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]